New drug designed to prevent chronic migraines

The U-S Food and Drug Administration has approved a new drug said to be the first designed to prevent chronic migraines.

Aimovig is a monthly shot developed by American drug maker Amgen and drug giant Novartis AG, and will cost almost seven-thousand dollars a year without insurance.

Current prevention treatments include pills originally developed for epilepsy and other conditions and the wrinkle reducer Botox, but many patients abandon them because they don’t help much or cause serious side effects.

Posted in News & Sports

+ Follow Us

 

Upcoming Events

  1. Karaoke @ Club Scorpio

    May 22 @ 8:00 pm - May 23 @ 12:00 am
  2. Dave’s Pot Party

    May 25 @ 7:00 pm - 9:00 pm
  3. 23rd Annual Barn Sale

    May 26 @ 7:30 am - 12:00 pm
  4. Christie Antique & Vintage Show

    May 26 @ 8:00 am - 5:00 pm
  5. Karaoke @ Club Scorpio

    May 29 @ 8:00 pm - May 30 @ 12:00 am

+ On-Air & Shows